Disclaimer

PLEASE READ THE INFORMATION BELOW CAREFULLY. The information below applies to anyone reading this white paper. Since the Cling White Paper (hereinafter "White Paper") is prepared and provided as of the time of writing, anything contained in the White Paper may be changed or updated at any time at the discretion of the Cling Team, and we do not guarantee that nothing in this White Paper will be changed until the future.

If you have any doubts about the contents of this White Paper, you should consult an accountant, lawyer or other professional before purchasing.

1. The purpose of this White Paper is to cover the summary and introduction to Cling that the Cling team is preparing. This White Paper is not legally binding on Cling or to the Cling Team, and nothing in the White Paper is intended to be a subscription, purchase, offer or solicitation to invest. In addition, this White Paper does not guarantee the applicability of laws such as the Medical Act and the Personal Information Protection Act.

2. Please note that all information or analysis in this White Paper cannot be used as a basis for any investment decisions and is not an investment proposal or advice of any kind. Please be advised that any forward-looking content or data in this White Paper is subject to change and may not be accurate for any reason, and there is no guarantee or commitment as to its contents.

3. The Cling team, including directors, agents, employees, contractors, sales partners, shall not be liable for damages of any kind, directly or indirectly, which may arise from the information contained herein, including: (1) the accuracy and completeness of the terms of the agreement in accordance with the applicable White Paper; (2) errors or omissions in the White Paper; (3) inability to access the White Paper due to unidentified causes; (4) all other damages arising from the use or non-use of the White Paper.

In addition, the Cling Team shall not be solely liable if prior warning has been given or such damages are foreseeable as a result of any decision made using the information contained herein: (1) profits, revenues, liabilities and any other form of monetary damages; (2) income, sales, reduction in equity, debt and other losses incurred in connection with business transactions, business activities, or operating income-related activities; (3) data loss or corruption; (4) incidental or special damages; (5) wasted or lost administrative time; (6) Indirect or consequential damages

4. The content of the White Paper may vary depending on the ongoing content of Cling, market changes, technological developments, and changes in ICO or token regulations. However, the Cling team is under no obligation to notify or report to readers of any events, platforms, future plans, changes in estimates, or changes within the margin of error in the future.

5. Please note that the information in this White Paper on areas such as law, tax, regulation, finance and accounting is not advice. The purchase of tokens may result in material losses to buyers, including the material assets paid for the purchase of tokens. Prior to purchasing tokens, buyers are advised to consult with tax, regulatory, financial, legal, etc. experts about the potential risks, returns, and possible consequences of trading tokens.

6. It is entirely up to CVTX purchasers to determine whether they are legally eligible for the disposal of income tax and other matters that may arise in connection with the acquisition and disposal of $CVTX tokens ("CVTX") within their own legal jurisdiction and for overseas currency exchange.

7. Copying, modifying, publishing or distributing all or parts of the contents of this White Paper in any country or region that illegally regulates the contents of the White Paper is prohibited. If people from these countries or regions invest, the team and company are not responsible for this, as the buyer takes the risk himself. The information in this White Paper has not been verified or approved by any regulatory body, and any action contrary to law is not effective against the Cling team. We do not guarantee that the publication and distribution of this White Paper complies with all the regulations of the country in which it was issued.

8. The official materials for Cling are this White Paper and are written in English. This White Paper may be translated into other languages and can be used to communicate orally or in writing with prospective and existing purchasers. However, some information may be misinterpreted or lost translation process. Therefore, please note that the accuracy of these alternative communications cannot be guaranteed. In the event of such inaccurate communication, the information in this Official White Paper in English shall prevail. However, this does not imply that Cling's affiliates and the Cling team, including directors, employees and representatives, are legally responsible for the contents of this White Paper.

9. All White Paper contents are protected by copyright. You may download or print individual sections of the white paper only for personal use or other proprietary notices. You may not reproduce or modify, link to, or use this White Paper for any public or commercial purpose, in whole or in part, by electronic means or otherwise, without the prior written permission of the Cling team.